Breadcrumb Home Merck & Co. Politics & Policy PBM bills drove lobbying spending in 2023 Insurance Federal PBM probe culminates decades of M&A Supply Chain Is Paxlovid, the COVID pill, reaching those who most need it? The government won’t say Policy New York City says it is ready to take on ‘Test to Treat' initiative Clinical How has the COVID-19 pandemic changed after two years? Safety FDA curbs use of antibody drugs sidelined by omicron Supply Chain COVID-19 pill rollout stymied by shortages as omicron rages Law & Regulation U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19 Safety & Quality Pfizer pill becomes 1st U.S.-authorized home COVID treatment Supply Chain Pfizer confirms COVID pill's results, potency versus omicron Load More Sponsored Content
